MediPal Holdings Corporation
7459
Pozycja w akcjach
#4251
Medipal Holdings Corporation, a Tokyo, Japan-based company founded in 1898,... Medipal Holdings Corporation, a Tokyo, Japan-based company founded in 1898, primarily specializes in the wholesale distribution of prescription pharmaceuticals throughout Japan. The firm procures a broad spectrum of healthcare products, including medical equipment, materials, and clinical diagnostic reagents, utilized across diagnostics, testing, treatment, and administration, often from the pre-symptomatic stage. It also offers contract-based post-marketing surveillance (PMS) services to manufacturers and strategically invests in products like orphan drugs. Beyond pharmaceuticals, Medipal Holdings diversifies its wholesale activities to encompass cosmetics, daily necessities, and over-the-counter medications. Its extensive product portfolio further includes animal health products for companion animals, raw materials for food processing in the agricultural, fisheries, and livestock sectors, along with livestock feed additives, various seasonings, veterinary medical equipment, packaging materials, and industrial chemicals. The company also provides a comprehensive suite of specialized services. These include conducting contract epidemiological and clinical studies, creating computerized databases for medical supplies and master product data for healthcare facilities, and offering health insurance claims reviews, medical coding dispatch, outsourcing, and remote education. Medipal's operations extend to life and non-life insurance agency services, cleaning management, the full management and operation of distribution centers, commissioned delivery, and worker dispatch. Additionally, it handles the planning, management, administration, and product/service development for its branded Class A health dispensing pharmacies. Serving an expansive client base, Medipal Holdings partners with hospitals, clinics, dispensing pharmacies, drugstores, home centers, convenience stores, supermarkets, discount stores, animal hospitals, livestock and fishery businesses, and processed food manufacturers. The company adopted its current name, Medipal Holdings Corporation in October 2009, having previously operated as Mediceo Paltac Holdings Co., Ltd.
Cena akcji
$20.55
Kapitalizacja rynkowa
$3.73B
Zmiana (1 dzień)
0.77%
Zmiana (1 rok)
22.26%
Kraj
JP
Handel MediPal Holdings Corporation (7459)
Kategoria
Healthcare
Marża operacyjna dla MediPal Holdings Corporation (7459)
Marża operacyjna na dzień October 2026 TTM: 1.36%
Według najnowszych raportów finansowych i ceny akcji MediPal Holdings Corporation, bieżąca marża operacyjna (TTM) wynosi 1.36%. Na koniec 2024 wynosiła 1.33%.
Historia marży operacyjnej dla MediPal Holdings Corporation od 2005 do 2026
Marża operacyjna na koniec każdego roku
| Rok | Marża operacyjna | Zmień |
|---|---|---|
| 2026 (TTM) | 1.36% | -9.93% |
| 2025 | 1.51% | 13.53% |
| 2024 | 1.33% | -8.90% |
| 2023 | 1.46% | 5.04% |
| 2022 | 1.39% | 15.83% |
| 2021 | 1.20% | -26.38% |
| 2020 | 1.63% | 3.82% |
| 2019 | 1.57% | 11.35% |
| 2018 | 1.41% | 9.30% |
| 2017 | 1.29% | -7.86% |
| 2016 | 1.40% | 22.81% |
| 2015 | 1.14% | -3.39% |
| 2014 | 1.18% | 16.83% |
| 2013 | 1.01% | 32.89% |
| 2012 | 0.76% | 49.02% |
| 2011 | 0.51% | -29.17% |
| 2010 | 0.72% | 30.91% |
| 2009 | 0.55% | -55.65% |
| 2008 | 1.24% | -3.13% |
| 2007 | 1.28% | 19.63% |
| 2006 | 1.07% | 62.12% |
| 2005 | 0.66% | 0.00% |
Marża operacyjna dla podobnych firm lub konkurentów
| Firma | Marża operacyjna | Różnica w marży operacyjnej | Kraj |
|---|---|---|---|
| 1.62% | -98.81% |
US
|
|
| 0.00% | - |
US
|
|
| 1.03% | -99.24% |
US
|
|
| 0.00% | - |
US
|
|
| 9.21% | -93.23% |
AU
|
Czym jest marża operacyjna firmy?
Marża operacyjna to kluczowy wskaźnik do oceny rentowności firmy. Wyższe marże operacyjne są zazwyczaj korzystniejsze, ponieważ pokazują, że firma może sprzedawać swoje produkty lub usługi znacznie drożej niż koszty ich produkcji. Oblicza się ją, dzieląc zysk firmy przez jej przychody.